153 related articles for article (PubMed ID: 25518363)
1. [Cancer stem cells in prostate cancer].
Nishida S; Masumori N
Nihon Rinsho; 2014 Dec; 72(12):2229-33. PubMed ID: 25518363
[TBL] [Abstract][Full Text] [Related]
2. Prostate cancer stem/progenitor cells: identification, characterization, and implications.
Tang DG; Patrawala L; Calhoun T; Bhatia B; Choy G; Schneider-Broussard R; Jeter C
Mol Carcinog; 2007 Jan; 46(1):1-14. PubMed ID: 16921491
[TBL] [Abstract][Full Text] [Related]
3. Stem cells: The root of prostate cancer?
Kasper S
J Cell Physiol; 2008 Aug; 216(2):332-6. PubMed ID: 18459113
[TBL] [Abstract][Full Text] [Related]
4. Stem cells in prostate cancer.
Mateo F; Fernandez PL; Thomson TM
Arch Esp Urol; 2013 Jun; 66(5):475-86. PubMed ID: 23793765
[TBL] [Abstract][Full Text] [Related]
5. Revisiting the concept of cancer stem cells in prostate cancer.
Wang ZA; Shen MM
Oncogene; 2011 Mar; 30(11):1261-71. PubMed ID: 21119602
[TBL] [Abstract][Full Text] [Related]
6. [Prostate cancer stem cell and drug resistance].
Kosaka T; Oya M
Nihon Rinsho; 2016 Jan; 74(1):45-9. PubMed ID: 26793878
[TBL] [Abstract][Full Text] [Related]
7. Identification, characterization, and biological relevance of prostate cancer stem cells from clinical specimens.
Kasper S
Urol Oncol; 2009; 27(3):301-3. PubMed ID: 19414117
[TBL] [Abstract][Full Text] [Related]
8. Regulators of prostate cancer stem cells.
Kerr CL; Hussain A
Curr Opin Oncol; 2014 May; 26(3):328-33. PubMed ID: 24651383
[TBL] [Abstract][Full Text] [Related]
9. Prostate cell cultures as in vitro models for the study of normal stem cells and cancer stem cells.
Miki J; Rhim JS
Prostate Cancer Prostatic Dis; 2008; 11(1):32-9. PubMed ID: 17984999
[TBL] [Abstract][Full Text] [Related]
10. Prostate cancer stem cells and their potential roles in metastasis.
Li H; Tang DG
J Surg Oncol; 2011 May; 103(6):558-62. PubMed ID: 21480250
[TBL] [Abstract][Full Text] [Related]
11. Overlapping genes may control reprogramming of mouse somatic cells into induced pluripotent stem cells (iPSCs) and breast cancer stem cells.
Mosca E; Cocola C; Sabour D; Pelucchi P; Bertalot G; Palumbo O; Carella M; Götte M; Schöler HR; Reinbold R; Zucchi I; Milanesi L
In Silico Biol; 2010; 10(5-6):207-21. PubMed ID: 22430355
[TBL] [Abstract][Full Text] [Related]
12. MicroRNAs involved in regulating epithelial-mesenchymal transition and cancer stem cells as molecular targets for cancer therapeutics.
Xia H; Hui KM
Cancer Gene Ther; 2012 Nov; 19(11):723-30. PubMed ID: 22975591
[TBL] [Abstract][Full Text] [Related]
13. Insights into the cell of origin in breast cancer and breast cancer stem cells.
Lindeman GJ; Visvader JE
Asia Pac J Clin Oncol; 2010 Jun; 6(2):89-97. PubMed ID: 20565420
[TBL] [Abstract][Full Text] [Related]
14. Therapy-induced developmental reprogramming of prostate cancer cells and acquired therapy resistance.
Nouri M; Caradec J; Lubik AA; Li N; Hollier BG; Takhar M; Altimirano-Dimas M; Chen M; Roshan-Moniri M; Butler M; Lehman M; Bishop J; Truong S; Huang SC; Cochrane D; Cox M; Collins C; Gleave M; Erho N; Alshalafa M; Davicioni E; Nelson C; Gregory-Evans S; Karnes RJ; Jenkins RB; Klein EA; Buttyan R
Oncotarget; 2017 Mar; 8(12):18949-18967. PubMed ID: 28145883
[TBL] [Abstract][Full Text] [Related]
15. Using self-assembled nanomaterials to inhibit the formation of metastatic cancer stem cell colonies in vitro.
Ling PM; Cheung SW; Tay DK; Ellis-Behnke RG
Cell Transplant; 2011; 20(1):127-31. PubMed ID: 20887677
[TBL] [Abstract][Full Text] [Related]
16. Molecular signature of cancer stem cells isolated from prostate carcinoma and expression of stem markers in different Gleason grades and metastasis.
Castellón EA; Valenzuela R; Lillo J; Castillo V; Contreras HR; Gallegos I; Mercado A; Huidobro C
Biol Res; 2012; 45(3):297-305. PubMed ID: 23283439
[TBL] [Abstract][Full Text] [Related]
17. A tumour stem cell hypothesis for the origins of prostate cancer.
Maitland NJ; Collins A
BJU Int; 2005 Dec; 96(9):1219-23. PubMed ID: 16287434
[TBL] [Abstract][Full Text] [Related]
18. ALDH activity indicates increased tumorigenic cells, but not cancer stem cells, in prostate cancer cell lines.
Yu C; Yao Z; Dai J; Zhang H; Escara-Wilke J; Zhang X; Keller ET
In Vivo; 2011; 25(1):69-76. PubMed ID: 21282737
[TBL] [Abstract][Full Text] [Related]
19. RNAi-mediated silencing of Myc transcription inhibits stem-like cell maintenance and tumorigenicity in prostate cancer.
Civenni G; Malek A; Albino D; Garcia-Escudero R; Napoli S; Di Marco S; Pinton S; Sarti M; Carbone GM; Catapano CV
Cancer Res; 2013 Nov; 73(22):6816-27. PubMed ID: 24063893
[TBL] [Abstract][Full Text] [Related]
20. Genomic analysis of prostate cancer stem cells isolated from a highly metastatic cell line.
Rowehl RA; Crawford H; Dufour A; Ju J; Botchkina GI
Cancer Genomics Proteomics; 2008; 5(6):301-10. PubMed ID: 19287071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
